Rights and permissions
About this article
Cite this article
IFN β-1a-based therapy effective, well-tolerated in hep C. Inpharma Wkly. 1606, 10 (2007). https://doi.org/10.2165/00128413-200716060-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716060-00027